4.2 Review

Cardiac Contractility Modulation Implications in Heart Failure, a Current Review

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM-HFpEF)

Cecilia Linde et al.

Summary: This pilot study aimed to assess the potential benefits of Cardiac Contractility Modulation (CCM) in patients with Heart Failure with Preserved Ejection Fraction (HFpEF). The study found that CCM significantly improved the health status of HFpEF patients without obvious safety concerns.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Chemistry, Multidisciplinary

Effects of Cardiac Contractility Modulation Therapy on Right Ventricular Function: An Echocardiographic Study

Carla Contaldi et al.

Summary: Cardiac contractility modulation (CCM) therapy improves left ventricular reverse remodeling and function in heart failure patients, but little evidence exists regarding its effects on right ventricular (RV) function. This study found that after six months of CCM therapy, patients showed improved RV systolic function, reduced pulmonary artery systolic pressure, and improved RV-PA coupling.

APPLIED SCIENCES-BASEL (2022)

Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association

Salim S. Virani et al.

Summary: The American Heart Association, in partnership with the National Institutes of Health, publishes annual statistics on heart disease, stroke, and cardiovascular risk factors, including the impact of health behaviors and factors on cardiovascular health. The Statistical Update covers a range of clinical heart and circulatory conditions, providing data on quality of care, procedures, and economic costs. It serves as a critical resource for various stakeholders seeking the best available data on these factors and conditions.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system

Jurgen Kuschyk et al.

Summary: Cardiac contractility modulation therapy improved functional status, quality of life, and LVEF, while reducing heart failure hospitalization rates. Survival at 1 and 3 years was significantly better than predicted by the MAGGIC risk score.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Medicine, General & Internal

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Cardiac Contractility Modulation in Heart Failure: Mechanisms and Clinical Evidence

Alexis Barnes et al.

CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Optimizer Smart in the treatment of moderate-to-severe chronic heart failure

Courtney M. Campbell et al.

FUTURE CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction

Stefan D. Anker et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Article Cardiac & Cardiovascular Systems

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation

William T. Abraham et al.

JACC-HEART FAILURE (2018)

Article Cardiac & Cardiovascular Systems

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Sana M. Al-Khatib et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction 5-Year Outcomes

Kevin S. Shah et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Cardiac Contractility Modulation in a Model of Repaired Tetralogy of Fallot: A Sheep Model

Francois Roubertie et al.

PEDIATRIC CARDIOLOGY (2016)

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure

John J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Cardiac & Cardiovascular Systems

Cardiac contractility modulation in patients with advanced heart failure

Rami Kahwash et al.

EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2013)

Review Cardiac & Cardiovascular Systems

Cardiac Titin A Multifunctional Giant

Martin M. LeWinter et al.

CIRCULATION (2010)

Article Cardiac & Cardiovascular Systems

Impact of Cardiac Contractility Modulation on Left Ventricular Global and Regional Function and Remodeling

Cheuk-Man Yu et al.

JACC-CARDIOVASCULAR IMAGING (2009)

Article Cardiac & Cardiovascular Systems

Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure

Christian Butter et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

Article Cardiac & Cardiovascular Systems

Cardiac contractility modulation by non-excitatory currents: Studies in isolated cardiac muscle

CB Brunckhorst et al.

EUROPEAN JOURNAL OF HEART FAILURE (2006)

Article Medicine, General & Internal

The effect of cardiac resynchronization on morbidity and mortality in heart failure

JGF Cleland et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

AJ Moss et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)